Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis

Clinical and Experimental Rheumatology

Volumn 24, Issue 5, 2006, Pages 576-579

  Amoli, Mahsa M ^a   Martin, Javier ^b   Miranda Filloy, Jose A ^c   Garcia Porrua, Carlos ^c   Ollier, William E R ^d   Gonzalez Gay, Miguel A ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HOSPITAL XERAL CALDE   (Spain)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cutaneous leukocytoclastic angiitis; Cutaneous vasculitis; Cytokines; Henoch Sch nlein purpura; Macrophage migration inhibitory factor gene; Macrophages

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; CYSTEINE; DNA; GLYCINE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADOLESCENT; ADULT; ALLELE; ALLERGIC VASCULITIS; AMINO ACID SUBSTITUTION; ANAPHYLACTOID PURPURA; ARTHRALGIA; ARTICLE; CAPILLARY ELECTROPHORESIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DNA FLANKING REGION; FEMALE; GASTROINTESTINAL DISEASE; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEMATURIA; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LEUKOCYTOCLASTIC VASCULITIS; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; NEPHROTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEINURIA; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; SYSTEMIC DISEASE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY; KIDNEY DISEASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PURPURA, SCHOENLEIN-HENOCH; VASCULITIS, HYPERSENSITIVITY;

EID: 33845510071     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. GONZALEZ-GAY MA, GARCIA-PORRUA C: Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001; 27:729-49.
2. GONZALEZ-GAY MA, CALVIÑO MC, VAZQUEZ-LOPEZ ME et al.: Implications of upper respiratory tract infections and drugs in the clinical spectrum of Henoch-Schönlein purpura in children. Clin Exp Rheumatol 2004; 22: 781-4.
3. JENNETTE JC, FALK RJ, ANDRASSY K et al.: Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
4. GARCIA-PORRUA C, LLORCA J, GONZALEZ-LOUZAO C, GONZALEZ-GAY MA: Hypersensitivity vasculitis in adults: a benign disease usually limited to skin. Clin Exp Rheumatol 2001; 19: 85-8.
5. AMOLI MM, THOMSON W, HAJEER AH et al.: HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from Northwest Spain. J Rheumatol 2001; 28:1266-270.
6. AMOLI MM, THOMSON W, HAJEER AH et al.: HLA-B35* association with nephritis in Henoch-Schönlein purpura. J Rheumatol 2002; 29: 948-9.
7. AMOLI MM, MATTEY DL, CALVIÑO MC et al.: Polymorphism at codon 469 of the intercellular adhesion molecule-1 (ICAM-1) locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura. J Rheumatol 2001; 28: 1014-8.
8. AMOLI MM, THOMSON W, HAJEER AH et al.: Interleukin-1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 2002; 29: 1404-07.
9. AMOLI MM, THOMSON W, HAJEER AH et al.: Interleukin-8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 2002; 29: 2367-70.
10. AMOLI MM, CALVINO MC, GARCIA-PORRUA C, LLORCA J, OLLIER WE, GONZALEZ-GAY MA: Interleukin lbeta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 2004; 31: 295-8.
11. SHIMIZU T, ABE R, NISHIHIRA J et al.: Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice. Eur J Immunol 2003; 33:1478-87.
12. LEECH M, METZ C, HALL P et al.: Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999; 42: 1601-8.
13. OHWATARI R, FUKUDA S, IWABUCHI K, INUYAMA Y, ONOE K, NISHIHIRA J: Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis. Ann Otol Rhinol Laryngol 2001; 110: 1035-40.
14. AMICHAI B, GRUNWALD MH, HALEVY S: Allergic vasculitis induced by Decapeptyl: confirmation by macrophage migration inhibition factor (MIF) test. Ear J Obstet Gynecol Reprod Biol 1993; 52: 217-8.
15. YOSHIOKA K, TAKEMURA T, AYA N, AKANO N, MIYAMOTO H, MAKI S: Monocyte infiltration and cross-linked fibrin deposition in IgA nephritis and Henoch-Schoenlein purpura nephritis. Clin Nephrol 1989; 32: 107-12.
16. NOLASCO FE, CAMERON JS, HARTLEY B, COELHO A, HILDRETH G, REUBEN R: Intraglomerular T cells and monocytes in nephritis: study with monoclonal antibodies. Kidney Int 1987; 31: 1160-6.
17. DONN RP, SHELLEY E, OLLIER WE, THOMSON W: A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 1782-5.
18. BAUGH JA, CHITNIS S, DONNELLY SC et al.: A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3: 170-6.
19. DONN R, ALOURFI Z, DE BENEDETTI F et al.: Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2402-9.
20. AMOLI MM, DONN RP, THOMSON W et al.: Macrophage migration inhibitory factor gene poiymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 2002; 29: 1671-3.
21. CALABRESE LH, MICHEL BA. BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990; 33: 1108-13.
22. MILLS JA, MICHEL BA, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-21.
23. MICHEL BA, HUNDER GG, BLOCH DA, CALABRESE LH: Hypersensitivity vasculitis and Henoch-Schönlein purpura: A comparison between the 2 disorders. J Rheumatol 1992; 19: 721-8.
24. AMOLI MM, GARCIA-PORRUA C, OLLIER WE, GONZALEZ-GAY MA: Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis. J Rheumatol 2005; 32: 74-6.
25. SALVARANI C, CASALI B, NICOLI D: Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthritis Rheum 2003; 48: 3219-23.
26. AMOLI MM, GARCIA-PORRUA C, CALVINO MC, OLLIER WE, GONZALEZ-GAY MA: Lack of association between endothelial nitric oxide synthase polymorphisms and Henoch-Schönlein purpura. J Rheumatol 2004; 31: 299-301.
27. BUCALA R: Neuroimmunomodulation by macrophage migration inhibitory factor (MIF). Ann N Y Acad Sci 1998; 840: 74-82.
28. GREGERSEN PK, BUCALA R: Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum 2003; 48: 1171-6.
29. HOTTA O, YUSA N, OOYAMA M, UNNO K, FURUTA T, TAGUMA Y: Detection of urinary macrophages expressing the CD16 (Fc gamma RIII) molecule: a novel marker of acute inflammatory glomerular injury. Kidney Int. 1999; 55: 1927-34.
30. WORTHINGTON J: Investigating the genetic basis of susceptibility to rheumatoid arthritis. J Autoimmun 2005; 25 (Suppl): 16-20.